Johan Frostegard

Title: Johan Frostegard: Innovator in Therapeutic Compositions

Introduction

Johan Frostegard is a notable inventor based in Sweden. He has made significant contributions to the field of therapeutic compositions, particularly in the treatment and prevention of various medical conditions. His innovative work has garnered attention in the scientific community.

Latest Patents

Frostegard holds patents related to therapeutic compositions aimed at treating osteoarthritis. His invention focuses on novel methods and uses for the prophylaxis or treatment of this condition. Additionally, he has developed a patent concerning Annexin V for preventing atherothrombosis and plaque rupture. This invention identifies factors that lead to the rupture of atherosclerotic plaques and proposes the use of native Annexin V or its fragments to improve binding to carotid plaques, representing a novel mechanism for preventing atherothrombosis.

Career Highlights

Throughout his career, Johan Frostegard has worked with several prominent companies in the biotechnology sector. Notable among these are Athera Biotechnologies AB and Annexin Pharmaceuticals AB. His work in these organizations has contributed to advancements in therapeutic solutions for cardiovascular and joint-related conditions.

Collaborations

Frostegard has collaborated with esteemed colleagues, including Ulf De Faire and Anna Cederholm. These partnerships have further enriched his research and development efforts in the medical field.

Conclusion

Johan Frostegard is a distinguished inventor whose work in therapeutic compositions has the potential to impact the treatment of osteoarthritis and atherothrombosis significantly. His innovative approaches and collaborations highlight his commitment to advancing medical science.